Healthcare Stocks Closed Lower (PFE, SVNT, KG, MYL)

Pfizer Inc. (NYSE:PFE) slid 0.74% to $17.49. Pfizer Inc. is a research-based, global biopharmaceutical company. The Company applies science and its global resources to improve health and well-being at every stage of life.

The 52-week range of the stock is $14-$20.36. Over the past three months of trading sessions, the stock went up more than over 16%.

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) fell 4.64% to $11.51. Yesterday, the company said its attempt to find a buyer has been failed.

On Sept 15, the company’s Krystexxa was approved by the U.S. Food and Drug Administration, the stock and soared and the company also commented that it is planning to itself.

The stock opened at $12.30 and was trading within the range of $11.47-$12.59.

King Pharmaceuticals, Inc. (NYSE:KG) went down 0.14% to $14.14. King Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products and animal health products.

The stock went up more than 14% year-to-date.

Mylan Inc. (NASDAQ:MYL) lost 0.25% to $19.60. The company reported net earnings attributable to Mylan shareholders of $108.4 million, or 33 cents per share. That compared with a loss of $40 million, or 13 cents per share in the year-earlier period, when results were hurt by amortization of assets.

Excluding special items, Mylan earned 43 cents per share. Analysts on average expected 42 cents per share, according to Thomson Reuters.

The company reaffirmed it expects full-year 2010 earnings, excluding special items, of $1.55 to $1.65 per share. That would reflect growth of 19 percent to 27 percent over last year.